Publications & Works

Articles 86
All (86)
SCI-E, SSCI, AHCI (69)
SCI-E, SSCI, AHCI, ESCI (79)
ESCI (9)
Scopus (81)
TRDizin (25)
Other Publications (1)
Papers Presented at Peer-Reviewed Scientific Conferences 98

1. MEDICATION ADHERENCE IN MULTIPLE SCLEROSIS: IMPACT OF DISEASE SUBTYPE AND TREATMENT LINE IN A TERTIARY CARE SETTING

ESCP symposium on clinical pharmacy. From interprofessional education to interprofessional practice, Grenoble, France, 26 - 28 November 2025, pp.98, (Summary Text)

2.

61. Ulusal Nöroloji Kongresi, Antalya, Turkey, 13 - 17 December 2025, pp.138, (Summary Text)

6. EDSS Progression and Upper Extremity Disability Worsening in Multiple Sclerosis: Nine-Hole Peg Test Dynamics Across EDSS Strata

41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 24 - 26 September 2025, vol.31, pp.210-211, (Summary Text)

7. Distribution of Cerebral Lesions in Primary Central Nervous System Vasculitis

41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 24 - 26 September 2025, vol.31, pp.1045, (Summary Text)

8. Distribution of Cerebral Lesions in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 24 - 26 September 2025, vol.31, pp.784, (Summary Text)

9. Real-World Effectiveness and Safety of Eculizumab in AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder: A Multicenter Observational Study

41st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 24 - 26 September 2025, vol.31, pp.729-730, (Summary Text)

10.

12. Nöroimmünoloji Okulu, Girne, Cyprus (Kktc), 8 - 11 May 2025, pp.27, (Summary Text)

11. Distribution of Cerebral Lesions in Primary Central Nervous System Vasculitis

Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 5 - 09 April 2025, vol.104, (Summary Text)

12. Clinical and Radiological Features of Anti-MOG Associated Cerebral Cortical Encephalitis

Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 5 - 09 April 2025, vol.104, (Summary Text)

13. Exome-sequencing of Turkish Families with Multiple Sclerosis: Low Frequency and Rare Variant Contributions into Susceptibility

Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 5 - 09 April 2025, vol.104, (Summary Text)

14.

60. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 02 December 2024, pp.280, (Summary Text)

15. Alternate-Day Fingolimod Tapering: Impact on Rebound Disease Activity in Patients with Multiple Sclerosis

The 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Kobenhavn, Denmark, 18 September 2024, vol.30, pp.4-124, (Summary Text)

16. Aquaporin-1 antibodies in autoimmune inflammatory demyelinating disorders with predominant optic nerve & spinal cord involvement

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Denmark, 18 - 20 September 2024, vol.30, pp.885, (Summary Text)

17. Alternate-Day Fingolimod Tapering: Impact on Rebound Disease Activity in Patients with Multiple Sclerosis

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Denmark, 18 - 20 September 2024, pp.107, (Summary Text)

18. Comparative Analysis of Five-Year Clinical Outcomes of Autologous Hematopoietic Stem Cell Transplantation and Alemtuzumab in Multiple Sclerosis Patients

40th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Copenhagen, Denmark, 18 - 20 September 2024, vol.30, pp.1183, (Summary Text)

22. Comparative Analysis of Diagnostic Criteria for Radiologically Isolated Syndrome (S31.009)

75th American Academy of Neurology Annual Meeting, BOSTON, United States Of America, 22 - 27 April 2023, vol.100, (Summary Text)

26. B cell gene expression profile in different demyelinating diseases

International Molecular Immunology & Immunogenetics Congress V (MIMIC V), İzmir, Turkey, 20 - 22 October 2022, (Summary Text)

27. Impact of Retinoic Acid on Group 2 Innate Lymphoid Cell Plasticity in Patients with Relapsing-Remitting Multiple Sclerosis.

5th International Molecular Immunology & Immunogenetics Congress (MIMIC-V), İzmir, Turkey, 20 - 22 October 2022, pp.1, (Summary Text)

28. Paraplegia following lumbar puncture: a rare complication of spinal dural arteriovenous fistula

2nd Congress of European Academy of Neurology, Kopenhag, Denmark, 28 - 31 May 2016, (Summary Text)

29. Cladribine treatment in turkish MS patients

38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 26 - 28 October 2022, pp.889-890, (Summary Text)

30. Validity of the Turkish Version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis

11th Quadrennial Congress of the European-Association-of-Neuroscience-Nursing (EANN), Manchester, England, 19 - 22 March 2022, (Summary Text)

34. Multipl Skleroz Hastalarında Dimetil Fumarat: Bir Gerçek Yaşam Çalışması

57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Summary Text)

35. Çocuklarda Bilişsel Ölçüm Yetişkinlerden Farklı mı? 

6. Multipl Sklerozda Kognisyon Sempozyumu, İzmir, Turkey, 13 - 14 November 2021, (Summary Text)

36. Can OSMS be differentiated from NMOSD and MS by peripheral blood immunophenotyping?

15th International Society of Neuroimmunology (ISNI) Congress, Nice, France, 8 - 12 November 2021, (Unpublished)

37. Covid-19 Aşısı Sonrası Gelişen Optik Nöropati Olgusu

TOD 55.Ulusal Kongresi, Antalya, Turkey, 03 November 2021, pp.131, (Summary Text)

38. “Ağır” Engellilik: Yatağa Bağımlı Olmak Nedenleri

5. Multipl Sklerozda Fiziksel Engellilik Sempozyumu, İzmir, Turkey, 22 - 23 May 2021, (Summary Text)

40. NFL Fiziksel Engellilikte Prognostik Etmen Olabilir mi?

4. Multipl Sklerozda Fiziksel Engellilik Sempozyumu, Turkey, 6 - 07 November 2020, (Summary Text)

41. Bilişsel Tutulumda Progresyon – Biyolojik Belirteç İlişkisi

5. Multipl Sklerozda Kognisyon Sempozyumu, Turkey, 6 - 07 November 2020, (Summary Text)

43. Analysis of Lesion Localization Pattern of Patients with Parenchymal Neuro-Behcet's Disease Using Probability Mapping

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

44. Cortical Laminar Necrosis Following the Rapid Correction of Hyponatremia-A Case Report

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

46. Recurrent Intracerebral Hemorrhage Due to Alemtuzumab Treatment in a Patient with Multiple Sclerosis: Case Report

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

47. Natural Course of Relapsing Tumefactive Multiple Sclerosis and Tumefactive Demyelinating Lesions

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

48. Doz Azaltarak Kesme Stratejisi Fingolimod Sonrası Rebound Aktivitesini Engeller mi?

55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 15 - 21 November 2019, (Summary Text)

49. Parenkimal NöroBehçet Hastalığında Lezyon Dağılım Paterninin Olasılık Haritalaması Kullanarak Analizi

55. Ulusal Nöroloji Kongresi 15 Kasım – 21 Kasım 2019, Antalya, Antalya, Turkey, 15 - 21 November 2019, (Summary Text)

50. İstanbul Tıp Fakültesi’nin Alemtuzumab Gerçek Yaşam Verisi

55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 15 November - 21 September 2019, (Summary Text)

51. The Survival of Turkish Patients with Multiple Sclerosis

35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), Stockholm, Sweden, 11 - 13 September 2019, vol.25, pp.3-130, (Summary Text)

52. Rebound disease activity after cessation of fingolimod treatment

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 11 - 13 September 2019, vol.25, pp.552, (Summary Text)

53. The survival of patients with multiple sclerosis in Turkey

35th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) / 24th Annual Conference of Rehabilitation in MS, Stockholm, Sweden, 11 - 13 September 2019, pp.47, (Summary Text)

55. Spastisitenin ölçümü

3. Multipl Sklerozda Fiziksel Engelliliğin Ölçümü Sempozyumu, İzmir, Turkey, 18 - 19 May 2019, (Summary Text)

56. Long-Term Follow-Up and Results of Patients with MRI Negative Demyelinating Diseases

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text)

58. Teriflunomid Tedavisinin Multipl Skleroz ile İlişkili Üveit Üzerine Etkisi

Nöro-oftalmoloji – Nöro-otoloji sempozyumu 2019, İstanbul, Turkey, 22 - 24 March 2019, (Summary Text)

63. Nöro-behçet Hastalığı Ne Kadar Süre Tedavi Edilmeli?

54. Ulusal Nöroloji Kongresi, Turkey, 30 November - 06 December 2018, (Summary Text)

65. Is placebo effect getting bigger in randomized controlled trials of multiple sclerosis?

34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Germany, 10 - 12 October 2018, pp.971-972, (Summary Text)

66. Predictors for conversion of radiologically isolated syndrome to multiple sclerosis

34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, Germany, 10 - 12 October 2018, pp.760-761, (Summary Text)

69. Long-term follow-up of patients with Neuro-Behcet's disease

4th Congress of the European-Academy-of-Neurology (EAN), Lisbon, Portugal, 16 - 19 June 2018, pp.355, (Summary Text)

70. A Patient with 4H Syndrome Who Presents in Adulthood

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text)

74. Genetic polymorphism of aquaporin-4 gene in neuromyelitis optica spectrum disorder

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 25 - 28 October 2017, pp.692-693, (Summary Text)

75. Comorbid autoimmunity is not a prognostic factor in multiple sclerosis

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 25 - 28 October 2017, pp.486, (Summary Text)

76. Neuro-behcet's disease: Analysis of 430 patients

23rd World Congress of Neurology (WCN), Kyoto, Japan, 16 - 21 September 2017, pp.121-122, (Summary Text)

77. HoxB3, a novel biomarker that predicts conversion to multiple sclerosis

7th Joint European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)-Americas-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ACTRIMS), Paris, France, 25 - 28 October 2017, pp.428-429, (Summary Text)

79. Pseudotumor Cerebri Related to Behçet's disease

3rd Congress of the European Academy of Neurology, Amsterdam, Netherlands, 24 - 27 June 2017, (Summary Text)

80. Pseudotumor cerebri related to Behcet's disease

3rd Congress of the European-Academy-of-Neurology, Amsterdam, Netherlands, 01 June 2017, pp.283, (Summary Text)

82. Nöromiyelitis Optika Hastalarında Aquaporin-4 Gen Polimorfizmi

52. Ulusal Nöroloji Kongresi, Antalya, Turkey, 25 November - 01 December 2016, (Full Text)

85. Multipl Skleroz Hastalarının Doğum Ayı İle Cinsiyet Arasında Bir İlişki Var mı?

52. Ulusal Nöroloji Kongresi, Tartışmalı E-poster - 121, Turkey, 25 November - 01 December 2016, (Summary Text)

86. Worsening of trigeminal neuralgia by dalfampridine in patients with multiple sclerosis

32nd Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), London, Canada, 14 - 17 September 2016, pp.814-815, (Summary Text)

87. Comparison of Mitoxantrone versus Cyclophosphamide in Patients with Secondary Progressive Multiple Sclerosis

2nd Congress of European Academy of Neurology, Kopenhag, Denmark, 28 - 31 May 2016, vol.23, pp.601-879, (Summary Text)

90. The effect of fingolimod treatment on peripheral blood cell immunophenotypes in patients with multiple sclerosis

International Molecular Immunology & Immunogenetcs Congress (MIMIC-III), Antalya, Turkey, 27 - 30 April 2016, vol.4, pp.75, (Full Text)

91. Withdrawal Rebound after Fingolimod in Multiple Sclerosis Patients

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Canada, 15 - 21 April 2016, vol.86, (Summary Text)

92. Switching From Glatiramer Acetate: Comparison of Disease Modifying Treatments

ACTRIMS Forum, Louisiana, United States Of America, 18 - 20 February 2016, vol.22, pp.18-19, (Summary Text)

96. A Case Of MRI Negative Neurobrucellosis With Isolated Spinal Cord Involvement

ICNC2012 (12th International Child Neurology Congress), Brisbane, Australia, 27 May - 01 June 2012, vol.54, pp.1-220, (Summary Text)

97. Familial effects on the age of onset, initial symptoms and clinical course of multiple sclerosis

20th Meeting of the European Neurological Society, Berlin, Germany, 19 - 23 June 2010, vol.257, pp.1-246, (Summary Text)
Books 10

1. Behçet’s Disease and Nervous System Involvement

in: Behçet's Disease: An Integrated Approach, ALPSOY ERKAN, BOVYAT AYŞE, ERGUN TÜLİN, Editor, Springer, pp.185-194, 2025

2. Merkezi Sinir Sisteminin Bariyerleri

in: Nöroimmünoloji, Yücesan Canan, Tuncer Aslı, Uzunköprü Cihat, Editor, Nobel Tıp Kitabevleri, İstanbul, pp.21-28, 2023

3. Akut Hemorajik Lökoensefalit

in: Nöroimmünoloji, Yücesan Canan, Tuncer Aslı, Uzunköprü Cihat, Editor, Nobel Tıp Kitabevleri, İstanbul, pp.233-237, 2023

4. Multipl Skleroz Tedavilerine İkincil Otoimmün Komplikasyonlar

in: Multipl Skleroz Tedavisinde Kullanılan İlaçların İzlem ve Güvenlik Kılavuzu, Bilge Piri Çinar, Aslı Tuncer, Hüsnü Efendi, Aksel Siva, Editor, Bayçınar Tıbbi Yayıncılık, Ankara, pp.99-106, 2022

5. Tele-Nöroloji

in: Tele Sağlık, Soysal Pınar, Tükek Tufan, Editor, İSTANBUL TIP KİTABEVLERİ, İstanbul, pp.308-327, 2022

6. Neuropsychiatric Symptoms in Neuro-Behçet’s Disease

in: Neuro-Behçet’s Disease, TÜZÜN ERDEM, KÜRTÜNCÜ MURAT, Editor, Springer, Cham, New York, pp.107-121, 2021

7. Merkezi Sinir Sisteminin Diğer Otoimmün ve İnflamatuar Demyelinizan Hastalıkları

in: Nöroloji, ÖGE ALİ EMRE, BAYKAL BETÜL, BİLGİÇ BAŞAR, Editor, NOBEL TIP KİTABEVİ, İstanbul, pp.797-819, 2021

8. Neuropsychiatric Symptoms in Neuro-Behçet’s Disease

in: Neuro-Behçet’s Disease Pathogenesis, Clinical Aspects, Treatment, ErdemTüzün; MuratKürtüncü, Editor, Springer, London/Berlin , Zürich, pp.107-123, 2021

9. Multipl Skleroz Ayırıcı Tanısı

in: Multipl Skleroz, Beckmann Yeşim, Uzunköprü Cihat, Editor, EMA Tıp Kitabevi ve Yayıncılık, İstanbul, pp.357-412, 2021

10. MULTİPL SKLEROZDA MONOKLONAL ANTİKORLAR

in: Multipl Skleroz tanı ve tedavi kılavuzu 2018, Hüsnü Efendi, Demet Yandım Kuşçu, Editor, Galenos Yayınevi, İstanbul, pp.86-108, 2018
Metrics

Publication

195

Publication (WoS)

118

Publication (Scopus)

81

Citation (WoS)

352

H-Index (WoS)

11

Citation (Scopus)

416

H-Index (Scopus)

12

Citation (Scholar)

469

H-Index (Scholar)

12

Citation (TrDizin)

6

H-Index (TrDizin)

1

Project

6

Open Access

11
UN Sustainable Development Goals